HopeStage
Back to all studies
CompletedNCT00807222

Lisdexamfetamine and sleep in children with ADHD

About this titleRead the official source — NCT00807222
Medication studyAges 6–12United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 6 years to 12 years.

Listed locations
Little RockSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2008
Recruitment status
Completed
Enrollment listed in the registry
24
Sponsor
Clinical Study Centers, LLC
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 6 Years to 12 Years
Official registry ID
NCT00807222
Official title
Show the full official title

Study of the Effect of Vyvanse (Lisdexamfetamine Dimesylate) on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Little Rock

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Clinical Study Centers, LLC.

Did this study involve medication?

Yes. The study involved medication, including lisdexamfetamine dimesylate.

Who was this study for?

Listed age limits: 6 years to 12 years.

Want to explore more studies?

Explore studies